e-learning
resources
London 2016
Tuesday, 06.09.2016
Biomarkers and phenotypes of COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Airway resistance correlates with the frequency of exacerbation in patient with COPD
Hitomi Furukawa (Tokyo, Japan), Hitomi Furukawa, Yasunari Kishino, Yasunori Murata, Shin Ohta, Tetsuya Honma, Sojiro Kusumoto, Mayumi Yamamoto, Shintaro Suzuki, Akihiko Tanaka, Takuya Yokoe, Tsukasa Ohnishi, Hironori Sagara
Source:
International Congress 2016 – Biomarkers and phenotypes of COPD
Session:
Biomarkers and phenotypes of COPD
Session type:
Thematic Poster
Number:
3668
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Hitomi Furukawa (Tokyo, Japan), Hitomi Furukawa, Yasunari Kishino, Yasunori Murata, Shin Ohta, Tetsuya Honma, Sojiro Kusumoto, Mayumi Yamamoto, Shintaro Suzuki, Akihiko Tanaka, Takuya Yokoe, Tsukasa Ohnishi, Hironori Sagara. Airway resistance correlates with the frequency of exacerbation in patient with COPD. Eur Respir J 2016; 48: Suppl. 60, 3668
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Frequency of COPD exacerbations and severity of COPD
Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations
Year: 2013
The bronchitic phenotype is associated with frequent exacerbations in COPD irrespective of chronic bacterial airway infection
Source: Annual Congress 2013 –Guidelines and exacerbations
Year: 2013
A pilot study of CPAP therapy for excessive dynamic airway collapse during acute exacerbation of COPD
Source: International Congress 2014 – COPD - from biomarkers to novel therapeutic opportunities
Year: 2014
COPD exacerbation: Influence of severity and type of systemic inflammation on the hospitalizations rate
Source: International Congress 2015 – COPD: chronic disease and comorbidities
Year: 2015
Emphysematous phenotype is an independent predictor for frequent exacerbation of chronic obstructive pulmonary disease (COPD)
Source: International Congress 2014 – Phenotyping and monitoring asthma and COPD
Year: 2014
Recording and response to hyperglycaemia in patients presenting with infective exacerbations of COPD
Source: Annual Congress 2013 –Difficult and rare respiratory infections
Year: 2013
Difficulty in management of COPD exacerbation: Is this chronic exacerbation or difficult COPD: “A specific phenotype?”
Source: Annual Congress 2013 –COPD biomarkers
Year: 2013
Spirometry quality in patients with COPD exacerbation, related to the “frequent exacerbator” phenotype
Source: Annual Congress 2013 –Reference, reliability and risk: advances in lung function
Year: 2013
Irisin is associated with severe exacerbations of COPD independently of lung function, comorbidities and exercise capacity
Source: International Congress 2015 – Notable abstracts in COPD: variety
Year: 2015
Clinical characteristics of patients with clinically-diagnosed COPD exacerbations but without concomitant airflow limitation
Source: International Congress 2015 – Notable abstracts in exacerbations, mechanisms and biomarkers in COPD
Year: 2015
Symptom profile of exacerbations in earlier and later COPD
Source: Annual Congress 2013 –Asthma and COPD: diseases with different phenotypes
Year: 2013
Factors associated with exacerbation in a general practitioners’-based Swiss chronic obstructive pulmonary disease (COPD) cohort
Source: Annual Congress 2013 –The best posters in chronic care
Year: 2013
Airway resistances deteriorate following spirometry in asthma and COPD patients
Source: International Congress 2016 – Functional assessment of the airways
Year: 2016
The clinical significance and frequency of bronchiectasis in COPD patients
Source: International Congress 2016 – Monitoring comorbidities
Year: 2016
Static hyperinflation and respiratory disability were associated with frequent-exacerbation phenotype in patients with severe COPD
Source: International Congress 2016 – Exploring mechanisms in health and disease
Year: 2016
Variability in exacerbation frequency in COPD patients
Source: Eur Respir J 2002; 20: Suppl. 38, 264s
Year: 2002
Frequency and severity of exacerbations reflect COPD severity, but not COPD phenotype as determined by quantitative CT
Source: International Congress 2014 – Markers
Year: 2014
The relation of comorbidities with the exacerbation severity in patients with COPD
Source: Annual Congress 2013 –COPD mechanisms
Year: 2013
Altered expression of glycosaminoglycans in the BAL of COPD patients with acute exacerbation
Source: Annual Congress 2013 –Translational studies in chronic lung diseases: from bedside to bench
Year: 2013
LATE-BREAKING ABSTRACT: Evaluating blood eosinophils and exacerbation history to predict ICS response in COPD
Source: International Congress 2016 – Late-breaking topics in airways disease
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept